Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

02. April 2026 20:10 ET | Quelle: Earth Echo

Cacao Bliss Claims Evaluated: The Natural GLP-1 Superfood Alternative, Earth Echo's Chocolate Drink Mix for Weight Loss

Earth Echo Foods details Cacao Bliss ceremonial-grade cacao formulation, GLP-1 research context, ingredient disclosures, and 2026 product terms.
02. April 2026 20:00 ET | Quelle: Kirby McInerney LLP

IBRX SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of ImmunityBio, Inc. Investors - Contact Kirby McInerney LLP by May 26, 2026

NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ:IBRX) securities to contact Lauren...
02. April 2026 18:44 ET | Quelle: AstralHQ

Genius Brain Signal Claims Evaluated: The 3-Minute Brain Song Wave Audio Protocol for Mental Health Support

Genius Brain Signal 2026: NASA study context, theta audio claims, 3-minute session research gaps, ClickBank refund terms, and buyer checklist.
02. April 2026 18:39 ET | Quelle: The Rosen Law Firm PA

UNIQURE DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before Important April 13 Deadline in Securities Class Action - QURE

NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) between September 24, 2025...
02. April 2026 18:33 ET | Quelle: Hagens Berman Sobol Shapiro LLP

ImmunityBio, Inc. (IBRX) Faces Securities Class Action Amid FDA Warning Regarding Unsupported Cancer Treatment Claims, $2 Billion Market Capitalization Wiped Out -- Hagens Berman

Investors who lost money in IBRX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
02. April 2026 18:20 ET | Quelle: Hagens Berman Sobol Shapiro LLP

CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss

Investors who lost money in CORT after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
02. April 2026 18:19 ET | Quelle: Hagens Berman Sobol Shapiro LLP

Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman

Investors who lost money in SLNO after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
02. April 2026 17:51 ET | Quelle: Bragar Eagel & Squire

UNIQURE DEADLINE APPROACHING: Bragar Eagel & Squire, P.C. Encourages uniQure N.V. Stockholders with Large Losses to Contact the Firm Before April 13th

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In uniQure (QURE) To Contact Him Directly To Discuss Their Options If you purchased or...
02. April 2026 16:58 ET | Quelle: FemiPro

FemiPro Claims Evaluated: Bladder Control Support with Clinically-Research Ingredients for Women's Urinary Microbiome Benefits

FemiPro 2026 consumer release: bladder control supplement ingredients, probiotic research, cranberry extract science, pricing, and buyer details.
02. April 2026 16:46 ET | Quelle: The Rosen Law Firm PA

INO FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INO

NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) between October...

Nächste Seite